The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Korotkikh S.A.

Kirov State Medical University

Shcherbakova O.V.

Yakovlev Ural State Law University

Derbenev O.A.

Kirov State Medical University

Selective intracoronary administration of glycoprotein IIb/IIIa inhibitors for acute myocardial infarction in a patient with COVID-19 during percutaneous coronary intervention

Authors:

Korotkikh S.A., Shcherbakova O.V., Derbenev O.A.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(2): 177‑183

DOI: 10.17116/kardio202215021177

Read: 1324 times

Download PDF (RU)
Contact the author
Table of contents

SELECTIVE INTRACORONARY ADMINISTRATION OF GLYCOPROTEIN IIB/IIIA INHIBITORS FOR ACUTE MYOCARDIAL INFARCTION IN A PATIENT WITH COVID-19 DURING PERCUTANEOUS CORONARY INTERVENTION
SELECTIVE INTRACORONARY ADMINISTRATION OF GLYCOPROTEIN IIB/IIIA INHIBITORS FOR ACUTE MYOCARDIAL INFARCTION IN A PATIENT WITH COVID-19 DURING PERCUTANEOUS CORONARY INTERVENTION

To cite this article:

Korotkikh SA, Shcherbakova OV, Derbenev OA. Selective intracoronary administration of glycoprotein IIb/IIIa inhibitors for acute myocardial infarction in a patient with COVID-19 during percutaneous coronary intervention. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(2):177‑183. (In Russ.)
https://doi.org/10.17116/kardio202215021177

 
ЭндоКард
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Morphofunctional and biochemical dete­rminants of endo­thelial function in patients with a new coro­navirus infe­ction COVID-19. Russian Journal of Preventive Medi­cine. 2024;(10):90-96
Inte­rventional radiological and endo­scopic technologies in diagnosis and treatment of chro­nic pancreatitis. Piro­gov Russian Journal of Surgery. 2024;(11):84-93
Loca­lization features of FAP-positive acti­vated stro­mal cells in fibrosis in patients with new coro­navirus infe­ction COVID-19. Russian Journal of Archive of Pathology. 2024;(6):5-14
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Lapa­roscopic appe­ndectomy for appe­ndiceal muco­cele in a patient with COVID-19. Endo­scopic Surgery. 2024;(6):41-45
Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medi­cine. 2024;(12):114-121
Sele­ctive anosmia for mono­molecular odorants in a cohort of young indi­viduals. Russian Rhinology. 2024;(4):262-268
The resu­lts of the examination of patients with chro­nic gene­ralized periodontitis after novel coro­navirus infe­ction. Russian Journal of Stomatology. 2024;(4):18-22
Waiting for Disease X: a plan for preparing Russian labo­ratory services for the next pandemic. Labo­ratory Service. 2024;(4):5-11
Diffuse changes in the brain in the acute phase of COVID-19 and after infe­ction. Russian Journal of Archive of Pathology. 2025;(1):5-15
Abstract:

To date, there are still no the targeted studies devoted to acute coronary syndrome or myocardial infarction in patients with COVID-19. The authors report selective intracoronary administration of glycoprotein IIb/IIIa inhibitor for acute myocardial infarction in a patient with COVID-19 during percutaneous coronary intervention.

Keywords:

eptifibatide
COVID-19
no-reflow
thrombaspiration
stenting

Authors:

Korotkikh S.A.

Kirov State Medical University

Shcherbakova O.V.

Yakovlev Ural State Law University

Derbenev O.A.

Kirov State Medical University

Received:

20.02.2021

Accepted:

20.04.2021

Close metadata

References:

  1. Sinayskaya MA, Kurochkina ON. Sex-adjusted risk factors of acute myocardial infarction-related mortality. Vyatka Medical Bulletin. 2017;3(55):19-27. (In Russ.).
  2. Iskhakov MM, Sayfullin RR, Yagafarov IR, et al. Primary percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction complicated by no-reflow phenomenon. Kazan Medical Journal. 2015;96(3):326. (In Russ.).
  3. Tereshchenko AS, Merkulov EV, Mironov VM, Shakhnovich RM, Samko AN. Manual thromboextraction in patients with acute myocardial infarction with ST-segment elevation. Atherothrombosis. 2016;1:39-49. (In Russ.).
  4. Gerasimov AM, Tereshchenko AS, Merkulov EV, Samko AN. No-reflow phenomenon in practice of endovascular surgeon. Journal of Radiology and Nuclear Medicine. 2014;1:51-55. (In Russ.).
  5. Demidova MM. Markers of reperfusion period in acute myocardial infarction with ST segment elevation and their prognostic value: Diss. ... d-ra med. nauk. SPb; 2016. (In Russ.).
  6. Frolov AA, Pochinka IG, Shakhov BE, Sharabrin EG, Kuzmichev KV. No-reflow phenomenon during percutaneous coronary interventions in patients with myocardial infarction. Circulatory Pathology and Cardiac Surgery. 2020;24(1):18-27. (In Russ.).
  7. Iskhakov MM, Tagirova DR, Gazizov NV, Nugaybekova LA, Sayfutdinov RG. The NO-REFLOW Phenomenon: Clinical Aspects of Reperfusion Failure. Kazan Medical Journal. 2015;96(3):391-396. (In Russ.). https://doi.org/10.17750/KMJ2015-391
  8. Tereshchenko AS, Merkulov EV, Samko AN. The use of IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Rational Pharmacotherapy in Cardiology. 2019;15(6):918-927. (In Russ.). https://doi.org/10.20996/1819-6446-2019-15-6-918-927
  9. Teplyakov DV. Angiographic assessment of coronary blood flow and myocardial perfusion in primary percutaneous coronary intervention and selective administration of eptifibatide: Diss. ... kand. med. nauk. SPb; 2017. (In Russ.).
  10. Kozlov IA, Tyurin IN. Cardiovascular complications of COVID-19. Bulletin of Anesthesiology and Intensive Care. 2020;17(4):14-22. (In Russ.). https://doi.org/10.21292/2078-5658-2020-17-4-14-22
  11. Tsui KL, Leung TC, Yam LY, So LK-Y, Poon E, Lung K-C, et al. Coronary plaque instability in severe acute respiratory syndrome. International Journal of Cardiology. 2005;99(3):471-472.  https://doi.org/10.1016/j.ijcard.2003.11.052
  12. Li YH, Wang MT, Huang WC, Hwang JJ. Management of acute coronary syndrome in patients with suspected or confirmed coronavirus disease 2019: Consensus from Taiwan Society of Cardiology. J Formos Med Assoc. 2021;120:78-82.  https://doi.org/10.1016/j.jfma.2020.07.017
  13. Rey JR, Jiménez Valero S, Poveda Pinedo D, Merino JL, López-Sendón JL, Caro-Codón J. COVID-19 and simultaneous thrombosis of two coronary arteries. Rev Esp Cardiol (Engl Ed). 2020;73(8): 676-677.  https://doi.org/10.1016/j.rec.2020.05.021
  14. Kurdi H, Obaid DR, UlHaq Z, Ionescu A, Sekar B. Multiple spontaneous coronary thrombosis causing ST-elevation myocardial infarction in a patient with COVID-19. Br J Hosp Med (Lond). 2020;81(7):1-6.  https://doi.org/10.12968/hmed.2020.0337
  15. Dominguez-Erquicia P, Dobarro D, Raposeiras-Roubín S, Bastos- Fernandez G, Iñiguez-Romo A. Multivessel coronary thrombosis in a patient with COVID-19 pneumonia. Eur Heart J. 2020;41(22):2132. https://doi.org/10.1093/eurheartj/ehaa393
  16. Setia G, Tyler J, Kwan A, Faguet J, Sharma S, Singh S, Azarbal B, Tompkins R, Chinchilla D, Ghandehari S. High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19. Rev Cardiovasc Med. 2020;21(2):289-295.  https://doi.org/10.31083/j.rcm.2020.02.92
  17. Sun B, Liu Z, Yin H, et al. Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes. Medicine. 2017;96(40):e8223. https://doi.org/10.1097/MD.0000000000008223
  18. Valchanov K, Krishnan U, Hoole SP, et al. COVID-19 patient with coronary thrombosis supported with ECMO and Impella 5.0 ventricular assist device: a case report. European Heart Journal. 2020;4(6):1-6.  https://doi.org/10.1093/ehjcr/ytaa342
  19. Kelham M, Choudry FA, Hamshere S, et al. Therapeutic Implications of COVID-19 for the Interventional Cardiologist. Journal of Cardiovascular Pharmacology and Therapeutics. 2021;26(3):203-216.  https://doi.org/10.1177/1074248420982736
  20. Decision of the Council of the Eurasian Economic Commission dated 03.11.16 No. 88 “On approval of requirements for instructions for medical drugs and general characteristics of drugs for medical use”. Consultant Plus. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.